BioPharma Credit (BOPCF) Short Interest Ratio & Short Volume $0.91 0.00 (0.00%) (As of 11/7/2024 ET) Add Share Share Short Interest Stock AnalysisChartShort Interest BioPharma Credit Short Interest DataBioPharma Credit (BOPCF) has a short interest of 11,900 shares. This marks a 5,850.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.4, indicating that it would take 4.4 days of the average trading volume of 274,765 shares to cover all short positions.Current Short Interest11,900 sharesPrevious Short Interest200 sharesChange Vs. Previous Month+5,850.00%Dollar Volume Sold Short$10,710.00Short Interest Ratio4.4 Days to CoverLast Record DateSeptember 15, 2024Today's Trading Volume0 sharesAverage Trading Volume274,765 sharesToday's Volume Vs. Average0% Short Selling BioPharma Credit? Sign up to receive the latest short interest report for BioPharma Credit and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBOPCF Short Interest Over TimeBOPCF Days to Cover Over TimeBOPCF Percentage of Float Shorted Over Time Ad Porter & CompanyUrgent: This election is riggedIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. BioPharma Credit Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/202411,900 shares $10,710.00 +5,850.0%N/A4.4 $0.90 8/31/2024200 shares $195.00 +100.0%N/A2 $0.98 8/15/2024100 shares $93.00 No ChangeN/A0 $0.93 7/31/2024100 shares $86.20 -97.5%N/A0 $0.86 7/15/20244,000 shares $3,448.00 -92.6%N/A0.8 $0.86 6/30/202454,000 shares $47,023.20 +53,900.0%N/A0.9 $0.87 6/15/2024100 shares $87.08 -50.0%N/A0 $0.87 5/31/2024200 shares $174.16 +100.0%N/A0 $0.87 5/15/2024100 shares $89.00 -50.0%N/A0 $0.89 4/30/2024200 shares $182.16 No ChangeN/A0 $0.91 4/15/2024200 shares $184.00 +100.0%N/A0 $0.92 3/31/2024100 shares $92.00 -50.0%N/A0 $0.92 3/15/2024200 shares $179.88 +100.0%N/A2 $0.90 2/29/2024100 shares $93.10 No ChangeN/A1 $0.93 8/15/20235,000 shares $4,350.00 No ChangeN/A0.1 $0.87 7/31/20235,000 shares $4,350.00 No ChangeN/A0.2 $0.87 BOPCF Short Interest - Frequently Asked Questions What is BioPharma Credit's current short interest? Short interest is the volume of BioPharma Credit shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 11,900 shares of BOPCF short. Learn More on BioPharma Credit's current short interest. What is a good short interest ratio for BioPharma Credit? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BOPCF shares currently have a short interest ratio of 4.0. Learn More on BioPharma Credit's short interest ratio. Is BioPharma Credit's short interest increasing or decreasing? BioPharma Credit saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 11,900 shares, an increase of 5,850.0% from the previous total of 200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($6.15 billion), Charter Communications, Inc. ($4.04 billion), Paychex, Inc. ($2.77 billion), Nu Holdings Ltd. ($2.71 billion), Cencora, Inc. ($2.34 billion), Aptiv PLC ($2.18 billion), Tractor Supply ($2.07 billion), International Paper ($2.01 billion), AppLovin Co. ($1.95 billion), and Moderna, Inc. ($1.89 billion). View all of the most shorted stocks. What does it mean to sell short BioPharma Credit stock? Short selling BOPCF is an investing strategy that aims to generate trading profit from BioPharma Credit as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioPharma Credit? A short squeeze for BioPharma Credit occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BOPCF, which in turn drives the price of the stock up even further. How often is BioPharma Credit's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BOPCF, twice per month. The most recent reporting period available is September, 15 2024. More Short Interest Resources from MarketBeat Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:BOPCF) was last updated on 11/8/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThis is treasonIf you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share BioPharma Credit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.